PARP Inhibitor for Ovarian Cancer Therapy. European Journal of Medical and Health Sciences, [S. l.], v. 4, n. 6, p. 1–7, 2022. DOI: 10.24018/ejmed.2022.4.6.1477. Disponível em: https://ej-med.org/index.php/ejmed/article/view/1477. Acesso em: 10 oct. 2025.